COMPANY PROFILE

Qualifyze

Explore full profile

Compliance oversight and predictive supplier risk management for life sciences companies

Frankfurt, GermanyFounded 2017Biotech & Life Sciences

Valuation $100–250M Last recorded · 2024

Headcount 100–500 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

About Qualifyze

Qualifyze operates in the pharmaceutical and supply chain sectors, providing comprehensive audit solutions to streamline compliance and supplier verification processes. The company serves pharmaceutical manufacturers, suppliers, and auditors by offering a vast database of GxP (Good Practice) audit reports. This database allows clients to access existing audit reports or join scheduled audits, significantly reducing the time and effort required to organize new audits. Qualifyze's platform is designed to simplify audit workflows, making it easier to secure, organize, and plan audits, thereby ensuring compliance with industry standards. The business model revolves around a subscription-based service and direct purchase options for audit reports, generating revenue through these channels. By offering a one-stop shop for all audit needs, Qualifyze enhances the efficiency and reliability of global supply chains.

Source: Dealroom company data

At a glance

Status: Operational
Founded: 2017
Headquarters: Frankfurt, Germany
Employees: 222
Open positions: 10
Dealroom signal: 70.0/100
Industry: Health
Sub-industry: Pharmaceutical
Sector: Biotech & Life Sciences, Supply Chain Management, Predictive Analytics, Core AI, Advanced Data Analytics, Tech for Biotech and Pharma, Governance, Risk and Compliance, AI Applications
Technology: Artificial Intelligence, Big Data
Business model: SaaS
Client focus: b2b
Links: Website LinkedIn X

Latest news

Press, funding announcements and product moves mentioning Qualifyze.

See all news

Funding history

6 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
LATE VCOther financing	Oct 2024	$0	—	Insight Partners	—
SERIES BOther financing	Sep 2024	$54M	$100M	HV Capital · HarbourVest Partners · Cherry Ventures · H14	↗

Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Qualifyze website traffic

Latest recorded traffic for Qualifyze is 9.2K monthly website visits, up 5.7% over the last three months. Qualifyze's team declined 0.9% over the past year.

Latest monthly visits9.2K 3-month web change+5.7% 1-year team growth-0.9%

Monthly website visitsAug 2020–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

Account Executive - NJJersey City, New Jersey, United States, Northern America, Americas · Accounting · Sep 4, 2026 Senior PM- life science productsBarcelona, Spain, Southern Europe, Europe · Other · Aug 28, 2026 Senior Backend Engineer (remote)Barcelona, Spain, Southern Europe, Europe · Backend Development · Aug 18, 2026 Staff Data Engineer (remote)Barcelona, Spain, Southern Europe, Europe · Data Science & Engineering · Aug 18, 2026 Java Backend Engineering Lead (remote)Barcelona, Spain, Southern Europe, Europe · Backend Development · Aug 18, 2026 Staff Data EngineerBarcelona, Spain, Southern Europe, Europe · Data Science & Engineering · Jul 29, 2026 Analytics EngineerBarcelona, Spain, Southern Europe, Europe · Business Intelligence · Jul 16, 2026 Quality Auditor (Poland)Warsaw, Poland, Eastern Europe, Europe · Accounting · Jul 2, 2026

8 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
PLPLAIOPLAIO creates innovative software solutions that add direct value to the pharmaceutical manufacturing and planning process	Reykjavík, Iceland	Operational	33	$8.1M	$19M
ANAnalysisModeAI platform for Biotech R and D empowering scientists to yield 5x more results	Helsinki, Finland	Operational
SYSynapseHealthTechAI-powered healthcare workflow and decision-making optimization	Dubai, United Arab Emirates	Operational
PAPatchAiA cognitive platform embedding an empathetic virtual assistant for patient engagement and real-time conversational data collection	Milan, Italy	Acquired
RLReverie LabsReverie Labs (YC W18) optimizes potential medicines using machine learning	Cambridge, United States	Acquired
PHPharmaticsDeveloping AI and machine learning solutions for digital health and precision medicine	Edinburgh, United Kingdom	Operational
PTPear TherapeuticsPear discovers, develops, and commercializes Prescription Digital Therapeutics to treat diseases with high unmet need	Boston, United States	Operational
NFnferenceArtificial intelligence to synthesize the exponentially growing biomedical knowledge	Cambridge, United States	Operational